Health CanadaGeneral Alert
Important Safety Information on CRYSVITA (burosumab) and the Risk of Severe Hype...
Published: August 25, 2025Recall ID: 77973Category: generalCountry: Canada
Reason for Recall / Hazard
New safety information - Product safety
Product Description & Identification
Important Safety Information on CRYSVITA (burosumab) and the Risk of Severe Hypercalcemia in Patients with Tertiary Hyperparathyroidism
Affected Products
CRYSVITA (burosumab)
Additional Source Details
| Field | Value |
|---|---|
| N I D | 77973 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/important-safety-information-crysvita-burosumab-and-risk-severe-hypercalcemia-patients |
| Issue | New safety information - Product safety |
| Title | Important Safety Information on CRYSVITA (burosumab) and the Risk of Severe Hypercalcemia in Patients with Tertiary Hyperparathyroidism |
| Product | CRYSVITA (burosumab) |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2025-08-25 |
| Organization | Marketed health products |